Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II Cabozantinib in Combination w/ Nivolumab in Advanced, Recurrent Metastatic Endometrial Cancer

Protocol: OSU-18067

Full Title

A Randomized Phase II Study of Cabozantinib in Combination with Nivolumab in Advanced, Recurrent Metastatic Endometrial Cancer

Gynecologic Cancers Endometrial Cancer